HM19 attendees discuss key take-home points from Monday’s Update in Sepsis session.
© Frontline Medical Communications 2018-2021. Reprinted with permission, all rights reserved.
Related Articles
Dalbavancin Non-Inferior, But Not Superior, to Standard Therapy for Treatment of Complicated Staphylococcus aureus Bacteremia
March 26, 2019
CLINICAL QUESTION: Among patients with complicated Staphylococcus aureus bacteremia who achieve blood culture clearance with initial therapy, is completion of treatment with dalbavancin superior to...
FMT is a Noninferior Treatment Option for Primary CDI
March 26, 2019
CLINICAL QUESTION: Is fecal microbiota transplantation (FMT) safe and efficacious in the treatment of primary Clostridioides difficile infection (CDI)? BACKGROUND: FMT is currently recommended for...
Comparing Screening Tools for Predicting Sepsis Among Children
March 26, 2019
CLINICAL QUESTION: Which screening tool performs best for early prediction of sepsis and septic shock in children per the Phoenix criteria? BACKGROUND: Early recognition of sepsis remains...
Significant Pathology in Young Infants Presenting with Hypothermia: A Multicenter Study
March 26, 2019
CLINICAL QUESTION: Among infants aged 90 days or younger who present to the emergency department (ED) or hospital with hypothermia, what is the prevalence of significant pathology, and what pathology...